Or it means that FDA is not doing its job properly. It could be do to lack of manpower or whatever but the fact that the FDA did not inspect the sites in question doesn't mean that the complaint wasn't justified. It just means it wasn't investigated, so no clear conclusions can be made.
There have been many scandals with pharma and regulators. Opioid crisis is one example, even though all involved parties currently blame each other and it has not been established who shares the most guilt yet. In either case, we definitely needed alarming articles about risks from newly marketed opioids 10 years ago.
The other worry is the recent approval of aducanumab by the FDA.
